Tamil Nadu has witnessed a significant breakthrough in cardiac care as Kovai Medical Center and Hospital (KMCH), Coimbatore, successfully implanted a dual-chamber retrievable leadless pacemaker, marking a major advancement in heart rhythm management.
The hospital announced that this procedure represents a dramatic shift from conventional pacemaker technology, offering patients a safer, more comfortable, and cosmetically superior alternative.
Traditional pacemakers require a small surgical incision in the chest and the placement of leads—thin wires that run under the skin and connect the device to the heart. While effective, this system poses limitations and risks, including lead fractures, dislodgements, and infections in the device pocket. In contrast, the new leadless pacemaker eliminates these components entirely.
The leadless device is a tiny, self-contained capsule, comparable in size to a large vitamin pill, and is delivered directly into the right atrium and right ventricle through a minimally invasive catheter inserted via the femoral vein. This approach avoids surgery, reduces recovery time, and minimizes complications.
KMCH Chairman Dr. Nalla G. Palaniswami said, “This transformative procedure signals the beginning of a new era in cardiology. Under the expert leadership of Dr. Lawrance Jesuraj, our team has successfully embraced a technology that provides patients a highly effective and far less invasive option.”
The hospital noted major benefits including reduced complication risks, faster healing, improved aesthetic outcomes, and enhanced patient comfort due to the absence of external wires or visible device bulges.
Dr. Lawrance Jesuraj added, “We are proud to bring this cutting-edge treatment to the people of Tamil Nadu. Our focus is on safer procedures and quicker recovery.”
Executive Director Dr. Arun Palaniswami highlighted KMCH’s leadership in electrophysiology, stating that introducing this device within a month of its Indian launch reinforces the hospital’s pioneering role. The retrievable nature of the device allows future upgrades or replacements—an advantage previous models lacked.
With this achievement, KMCH once again positions itself at the forefront of innovative cardiac care in the region.
